Samsung Medison Expands Hongcheon Ultrasound Manufacturing Facility, "Nearly Doubling Production Capacity"

Completion of a new 14,548-square-meter manufacturing facility
Growth in premium products incorporating AI
Expanded supply to medical institutions worldwide

Samsung Medison has completed a new manufacturing building for ultrasound diagnostic equipment in Hongcheon County, Gangwon State, and is strengthening its production capabilities to expand its presence in the global medical device market. The expansion is the largest production-facility investment since the company became part of Samsung Electronics. It is intended to meet rising demand for premium ultrasound diagnostic equipment and expand the company’s global supply base.

Samsung Medison said it held a completion ceremony for the expanded manufacturing building at its Hongcheon site on the 13th. Key attendees included Gangwon State Governor Woo Sangho, lawmaker Yoo Sangbum, Hongcheon County Governor Shin Youngjae, and Samsung Medison CEO Yoo Gyutae.

The new manufacturing building was expanded with an investment of 50 billion won and has a total floor area of 14,548 square meters (approximately 4,400 pyeong). It is the company’s largest investment in production facilities since Samsung Electronics acquired it in 2011. Through the expansion, Samsung Medison plans to nearly double its ultrasound diagnostic equipment production capacity by 2030 and develop its Hongcheon site into a key global supply hub.

The Hongcheon site is a key production hub for premium ultrasound diagnostic equipment, including the R20 and HERA Z20. It handles the entire process, from circuit board manufacturing and mechanical assembly to reliability testing and finished-product shipment. Products for export to more than 110 countries, which account for over 90% of Samsung Medison’s revenue, are also manufactured there.

A view of the new ultrasound diagnostic equipment manufacturing building at Samsung Medison’s Hongcheon site in Gangwon Special Self-Governing Province. Samsung Electronics.

The new manufacturing building features production lines and automated equipment designed to accommodate the characteristics of each process and the flow of materials. The company plans to optimize the movement of goods from parts receipt through assembly, inspection, and shipment, and to conduct a full inspection at every stage of production for every product to enhance quality competitiveness.

The company has also taken steps to improve energy efficiency. It has introduced Samsung Electronics’ b.IoT integrated building solution to manage heating, ventilation, and air conditioning (HVAC) systems and energy use centrally. The company said this can reduce reheating energy use by up to 33.6% and HVAC energy use by up to 15% with a building energy management system (BEMS). It has also installed high-efficiency temperature and humidity control equipment that can reduce power consumption by up to 52% compared with existing equipment.

Samsung Medison is also strengthening manufacturing synergies between its Hongcheon site and its Gumi site in North Gyeongsang Province. The Gumi site specializes in producing probes, key components that transmit and receive ultrasound. Recent expansions to production space and process improvements have increased its annual production capacity by approximately 17% from its previous level.

Samsung Medison, a South Korean medical device company founded in 1985, became a subsidiary of Samsung Electronics in 2011. It has expanded its business by applying Samsung’s electronics and IT technologies to ultrasound diagnostics, enhancing imaging performance and artificial intelligence (AI)-assisted diagnostic functions.

Attendees cut a ribbon at the completion ceremony for the expansion of the ultrasound diagnostic equipment manufacturing facility at Samsung Medison's Hongcheon plant in Gangwon Special Self-Governing Province on the 13th. (From third left) Hongcheon County Governor Shin Youngjae, Gangwon State Governor Woo Sangho, Samsung Medison CEO Yoo Gyutae, People Power Party lawmaker Yoo Sangbum, Gangwon State Council Chair Park Gilsun, G1 Gangwon Broadcasting President Jeon Jongryul, Hongcheon County Council Chair Jung Gwangyo, and Samsung Global Research President Kim Wanpyo, head of the Shared Growth Research team. Samsung Electronics.

Its growth in performance has continued. In 2025, while the global ultrasound diagnostic equipment market grew by 3.7%, Samsung Medison’s revenue increased by 16.2%. With the global market expected to grow by approximately 4% in 2026, the company expects to continue growing faster than the market average. It also aims to rank among the top three in the global ultrasound diagnostic equipment market by expanding its premium product lineup incorporating AI technology.

The company is also moving quickly to strengthen product competitiveness. After launching the HERA Z20 for obstetrics and gynecology in 2024 and the R20 for radiology in 2025, it expanded its premium lineup this year with the launch of the Z10 for obstetrics and gynecology. It is widening its presence in global markets by supplying products to major overseas medical institutions, including the Mayo Clinic and Cleveland Clinic in the United States and Karolinska University Hospital in Sweden.

The company is also seeking to identify new growth areas. It has established a dedicated development organization for cardiology and is working with Samsung Medical Center to develop products that reflect clinical needs. In the point-of-care (POC) field, it has launched the laptop-style EVO Q10 and the tablet-style EVO X10 ultrasound diagnostic equipment. It is also collaborating with HistoSonics to apply ultrasound imaging technology to treatment.

Samsung Medison CEO Yoo Gyutae said, “The expansion of our Hongcheon plant is an important turning point that will take Samsung Medison’s manufacturing competitiveness to the next level in the global medical device market, going beyond simply expanding production facilities. We will contribute to medical professionals and patients around the world through uncompromising quality and a stable supply of equipment, while continuing technological innovation to lead the global medical device market.”

This content was produced with the assistance of AI translation services.